[Allergen-specific immunotherapy provides long-lasting symptom relief]

Area of Science:

• Immunology
• Allergology
• Clinical Medicine

Background:

• Allergen immunotherapy (AIT) improves symptoms of allergic rhinoconjunctivitis and asthma.
• AIT may prevent asthma development in children with allergic rhinitis.
• Clinical effects are linked to a Th2 to Th1 immune response shift.

Purpose of the Study:

• To summarize the benefits and administration of allergen immunotherapy.
• To discuss the immunological mechanisms underlying AIT.
• To introduce novel administration routes for AIT.

Main Methods:

• Review of existing studies on allergen immunotherapy.
• Description of current AIT administration methods (sublingual, subcutaneous).
• Introduction of intralymphatic administration as a novel approach.

Main Results:

• AIT provides long-term symptom improvement and reduces medication needs.
• AIT is associated with a shift from Th2 to Th1 immune responses.
• Serious side-effects are rare with trained administration.

Conclusions:

• Allergen immunotherapy is an effective long-term treatment for pollen, cat, and house dust mite allergies.
• Intralymphatic administration shows promise for shortening treatment duration.
• Trained healthcare professionals are crucial for safe AIT administration.